Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00104026 · ClinicalTrials.gov registry record
Genes Associated With Hereditary and Drug-Induced Gingival Overgrowth
A clinical trial of Gingival Overgrowth, sponsored by National Institute of Dental and Craniofacial Research (NIDCR).
- Completed
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT00104026 is a study of Gingival Overgrowth that has completed, run by National Institute of Dental and Craniofacial Research (NIDCR). The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00104026, a study of Gingival Overgrowth, has completed, sponsored by National Institute of Dental and Craniofacial Research (NIDCR).
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine common features of gingival overgrowth (excessive growth of the gums around the teeth) that develops in patients with the hereditary form of the condition and in those who develop the condition as a side effect of medications. A better understanding of gingival overgrowth may help scientists develop medications with fewer oral side effects. Patients of any age with hereditary gingival fibromatosis and their blood relatives, and patients of any age with gingival overgrowth who are taking medications associated with development of the disorder, including phenytoin (diphenylhydantoin or Dilantin), cyclosporine, and calcium-channel blockers, may be eligible for this study. Participants undergo a medical and dental history, including a history of medication use; detailed examination of the teeth, periodontium, head, and neck; photographs of teeth with gingival overgrowth; dental x-rays; and blood tests. DNA is extracted from a blood sample to look for genes related to gingival overgrowth. Patients with gingival overgrowth are offered two options, as follows: * Tissue biopsy: A tissue sample is taken from each affected site, with a maximum of three biopsies. For the procedure, lidocaine is first injected into the gum to numb the tissue. Then, a cookie-cutter instrument is pushed into the numbed skin, and a small piece of tissue is removed. * Gingivectomy: Surgical removal of the overgrown gingival.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2005-02-15 |
| Est. Completion | 2011-04-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00104026
The ClinicalTrials.gov registry entry for NCT00104026 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Dental and Craniofacial Research (NIDCR), which has 91 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gingival Overgrowth appearing as the primary indexed condition, and to 0 interventions.
NCT00104026 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00104026 about?
NCT00104026 is a clinical study titled "Genes Associated With Hereditary and Drug-Induced Gingival Overgrowth". This study will examine common features of gingival overgrowth (excessive growth of the gums around the teeth) that develops in patients with the hereditary form of the condition and in those who develop the condition as a side effect of medications. A better understanding of gingival overgrowth may...
What is the current status of trial NCT00104026?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2005-02-15. Estimated completion is 2011-04-19.
What conditions does trial NCT00104026 study?
This clinical trial studies the following conditions: Gingival Overgrowth.
Who is sponsoring clinical trial NCT00104026?
This trial is sponsored by National Institute of Dental and Craniofacial Research (NIDCR), which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00104026 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.